Increases in inotropic state without change in heart rate: Combined use of dobutamine and zatebradine in conscious dogs

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 237-244

  Hettrick, Douglas A ^a   Pagel, Paul S ^a   Lowe, Dermot ^a   Tessmer, John P ^a   Warltier, David C ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bradycardic agents, specific; Dobutamine; Inotropes; Isovolumic relaxation; Myocardial contractility; Preload recruitable stroke work; Ventricle filling; Zatebradine

Indexed keywords

DOBUTAMINE; ZATEBRADINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DOG; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA;

ANIMALS; BENZAZEPINES; CARDIOTONIC AGENTS; DOBUTAMINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HEART RATE; HEMODYNAMIC PROCESSES;

EID: 0030571517     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00688-7     Document Type: Article

References (20)

1. Breall, J.A., J. Watanabe and W. Grossman, 1993, Effect of zatebradine on contractility, relaxation, and coronary blood flow, J. Am. Coll. Cardiol. 21, 471.
2. Colucci, W.S., A.R. Denniss, G.F. Leatherman, R.J. Quigg, P.L. Ludmer, J.D. Marsh and D.F. Gauthier, 1988, Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition, J. Clin. Invest. 81, 1103.
3. Glower, D.D., J.A. Spratt, N.D. Snow, J.S. Kabas, J.W. Davis, C.O. Olsen, G.S. Tyson, D.C. Sabiston, Jr. and J.S. Rankin, 1985, Linearity of the Frank-Starling relationship in the intact heart: The concept of preload recruitable stroke work, Circulation 71, 994.
4. Johnston, W.E., J. Vinten-Johansen, E. Tommasi and W.C. Little, 1991, ULFS-49 causes bradycardia without decreasing right ventricular systolic and diastolic performance, J. Cardiovasc. Pharmacol. 18, 528.
5. Leier, C.V., P.T. Heban, P. Huss, C.A. Bush and R.P. Lewis, 1978, Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure, Circulation 58, 466.
6. Loeb, H.S., J. Bredakis and R.M. Gunnar, 1977, Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure, Circulation 55, 375.
7. Meyer, M., W. Schillinger, B. Pieske, C. Holubarsch, C. Heilmann, H. Posival, G. Kuwajima, K. Mikoshiba, H. Just and G. Hasenfuss, 1995, Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy, Circulation 92, 778.
8. Meyer, S.L., G.C. Curry, M.S. Donsky, D.B. Twieg, R.W. Parkey and J.T. Willerson, 1976, Influence of dobutamine on hemodynamks and coronary blood flow in patients with and without coronary artery disease, Am. J. Cardiol. 38, 103.
9. Mikulic, E., J.N. Cohn and J.A. Franciosa, 1977, Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure, Circulation 56, 528.
10. Nagata, K., M. Iwase, T. Sobue and M. Yokota, 1995, Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure, J. Am. Coll. Cardiol. 25, 295.
11. Pagel, P.S., C.P. Harkin, D.A. Hettrick and D.C. Warltier, 1995, Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs, J. Pharmacol. Exp. Ther. 275, 127.
12. Raff, G.L. and S.A. Glantz, 1981, Volume loading slows left ventricular isovolumic relaxation rate: Evidence of load-dependent relaxation in the intact dog heart, Circ. Res. 48, 813.
13. Riley, D.C., G.J. Gross, J.P. Kampine and D.C. Warltier, 1987, Specific bradycardic agents, a new therapeutic modality for anesthesiology: Hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs, Anesthesiology 67, 707.
14. Rooke, G.A. and E.O. Feigl, 1982, Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting, Circ. Res. 50, 273.
15. Ruffolo Jr., R.R., 1987, Review: The pharmacology of dobutamine, Am. J. Med. Sci. 294, 244.
16. Sonnenblick, E.H., W.H. Frishman and T.H. LeJemtel, 1979, Dobutamine: a new synthetic cardioactive sympathetic amine, New Engl. J. Med. 300, 17.
17. Van Bogaert, P.P., M. Goethals and C. Simoens, 1990, Use- and frequency-dependent blockade by UL-FS 49 of the 1f pacemaker current in sheep cardiac Purkinje fibers, Eur. J. Pharmacol. 187, 241.
18. Vatner, S.F., R.J. McRitchie and E. Braunwald, 1974, Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs, J. Clin. Invest. 53, 1265.
19. Warltier, D.C., M. Zyvoloski, G.J. Gross, H.F. Hardman and H.L. Brooks, 1981, Redistribution of myocardial blood flow distal to a dynamic coronary arterial stenosis by sympathomimetic amines. Comparison of dopamine, dobutamine, and isoproterenol, Am. J. Cardiol. 48, 269.
20. Wynsen, J.C., P.D. O'Brien and D.C. Warltier, 1994, Zatebradine, a specific bradycardic agent, enhances the positive inotropic actions of dobutamine in ischemic myocardium, J. Am. Coll. Cardiol. 23, 233.